We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Compounds Target Key Enzyme Halting SARS-CoV-2 Replication

News   Jul 07, 2020 | Original story from University of South Florida Health (USF Health)

 
Compounds Target Key Enzyme Halting SARS-CoV-2 Replication

Three configurations of active sites where inhibitor GC-376 binds with the COVID-19 virus's main protease (drug target Mpro), as depicted by 3D computer modeling. Credit: Image generated by Yu Chen, University of South Florida Health, using X-ray crystallography

 
 
Advertisement
 

RELATED ARTICLES

100 Million-Year-Old Seabed Microbes Revived

News

Researchers reveal that given the right food in the right laboratory conditions, microbes collected from sediment as old as 100 million years can revive and multiply, even after laying dormant since large dinosaurs prowled the planet.

READ MORE

Four-Stranded DNA Plays a Role in Certain Types of Breast Cancer

News

Four stranded DNA structures called G-quadruplexes have been shown to play a role in certain types of breast cancer, providing a potential new therapeutic target.

READ MORE

How Bacteria Protect Themselves With Slime in Changing Temperatures

News

Researchers show that the bacterium Clostridium perfringens modulates biofilm structure, a protected mode of growth, at different temperatures by regulating the expression of the novel extracellular protein BsaA.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE